71 related articles for article (PubMed ID: 2830405)
1. High metalloproteinase inhibitor content of human cirrhosis and its possible conference of metastasis resistance.
Barsky SH; Gopalakrishna R
J Natl Cancer Inst; 1988 Mar; 80(2):102-8. PubMed ID: 2830405
[TBL] [Abstract][Full Text] [Related]
2. [Why are metastases in cirrhotic livers so rare?].
Seitz G
Ultraschall Med; 1989 Jun; 10(3):123-6. PubMed ID: 2672314
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study on tissue inhibitors of metalloproteinases in normal and pathological human livers.
Fukuda Y; Imoto M; Koyama Y; Miyazawa Y; Nakano I; Hattori M; Urano F; Kodama S; Iwata K; Hayakawa T
Gastroenterol Jpn; 1991 Feb; 26(1):37-41. PubMed ID: 1848826
[TBL] [Abstract][Full Text] [Related]
4. Purification of a metalloproteinase inhibitor from human rheumatoid synovial fluid.
Mercer E; Cawston TE; de Silva M; Hazleman BL
Biochem J; 1985 Nov; 231(3):505-10. PubMed ID: 3000352
[TBL] [Abstract][Full Text] [Related]
5. Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis.
Li J; Rosman AS; Leo MA; Nagai Y; Lieber CS
Hepatology; 1994 Jun; 19(6):1418-23. PubMed ID: 8188171
[TBL] [Abstract][Full Text] [Related]
6. Efficient purification of TIMP-2 from culture medium conditioned by human hepatoma cell line, and its inhibitory effects on metalloproteinases and in vitro tumor invasion.
Umenishi F; Umeda M; Miyazaki K
J Biochem; 1991 Aug; 110(2):189-95. PubMed ID: 1662201
[TBL] [Abstract][Full Text] [Related]
7. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
[TBL] [Abstract][Full Text] [Related]
8. Purification of rabbit bone inhibitor of collagenase.
Cawston TE; Galloway WA; Mercer E; Murphy G; Reynolds JJ
Biochem J; 1981 Apr; 195(1):159-65. PubMed ID: 6272744
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of metalloproteinase inhibitor activity in human ovarian follicular fluid.
Curry TE; Sanders SL; Pedigo NG; Estes RS; Wilson EA; Vernon MW
Endocrinology; 1988 Sep; 123(3):1611-8. PubMed ID: 2841101
[TBL] [Abstract][Full Text] [Related]
10. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma.
Hayasaka A; Suzuki N; Fujimoto N; Iwama S; Fukuyama E; Kanda Y; Saisho H
Hepatology; 1996 Nov; 24(5):1058-62. PubMed ID: 8903375
[TBL] [Abstract][Full Text] [Related]
11. Increase in type I and type III collagens in human alcoholic liver cirrhosis.
Rojkind M; Martinez-Palomo A
Proc Natl Acad Sci U S A; 1976 Feb; 73(2):539-43. PubMed ID: 1061156
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells.
Schultz RM; Silberman S; Persky B; Bajkowski AS; Carmichael DF
Cancer Res; 1988 Oct; 48(19):5539-45. PubMed ID: 3416307
[TBL] [Abstract][Full Text] [Related]
13. Immunolocalization of metalloproteinases and their inhibitor in the rabbit growth plate.
Brown CC; Hembry RM; Reynolds JJ
J Bone Joint Surg Am; 1989 Apr; 71(4):580-93. PubMed ID: 2539384
[TBL] [Abstract][Full Text] [Related]
14. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2.
Goldberg GI; Marmer BL; Grant GA; Eisen AZ; Wilhelm S; He CS
Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8207-11. PubMed ID: 2554304
[TBL] [Abstract][Full Text] [Related]
15. Increased type IV collagen-degrading activity in metastases originating from primary tumors of the human colon.
Karakiulakis G; Papanikolaou C; Jankovic SM; Aletras A; Papakonstantinou E; Vretou E; Mirtsou-Fidani V
Invasion Metastasis; 1997; 17(3):158-68. PubMed ID: 9702942
[TBL] [Abstract][Full Text] [Related]
16. Distribution of constitutive (COX-1) and inducible (COX-2) cyclooxygenase in postviral human liver cirrhosis: a possible role for COX-2 in the pathogenesis of liver cirrhosis.
Mohammed NA; Abd El-Aleem SA; El-Hafiz HA; McMahon RF
J Clin Pathol; 2004 Apr; 57(4):350-4. PubMed ID: 15047734
[TBL] [Abstract][Full Text] [Related]
17. The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression.
Lara-Pezzi E; Gómez-Gaviro MV; Gálvez BG; Mira E; Iñiguez MA; Fresno M; Martínez-A C; Arroyo AG; López-Cabrera M
J Clin Invest; 2002 Dec; 110(12):1831-8. PubMed ID: 12488433
[TBL] [Abstract][Full Text] [Related]
18. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
Terada T; Okada Y; Nakanuma Y
Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
[TBL] [Abstract][Full Text] [Related]
19. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P
Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143
[TBL] [Abstract][Full Text] [Related]
20. Expression of decorin, transforming growth factor-beta 1, tissue inhibitor metalloproteinase 1 and 2, and type IV collagenases in chronic hepatitis.
Dudás J; Kovalszky I; Gallai M; Nagy JO; Schaff Z; Knittel T; Mehde M; Neubauer K; Szalay F; Ramadori G
Am J Clin Pathol; 2001 May; 115(5):725-35. PubMed ID: 11345837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
